177 related articles for article (PubMed ID: 12270387)
1. Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation.
Kahl A; Oppert M; Müller A; Settmacher U; Lepenies J; Klupp J; Kampf D; Neuhaus P; Frei U
Transplant Proc; 2002 Sep; 34(6):2253-5. PubMed ID: 12270387
[No Abstract] [Full Text] [Related]
2. Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.
Burke GW; Ricordi C; Karatzas T; Carreno M; Markou M; Cirocco R; Ciancio G; Qian T; Selvaggi G; Alejandro R; Skyler JS; Roth D; Tzakis A; Miller J
Transplant Proc; 1997; 29(1-2):1207-8. PubMed ID: 9123275
[No Abstract] [Full Text] [Related]
3. Can acute rejection be prevented in SPK transplantation?
Burke G; Ciancio G; Figueiro J; Olson L; Gomez C; Rosen A; Suzart K; Miller J
Transplant Proc; 2002 Aug; 34(5):1913-4. PubMed ID: 12176626
[No Abstract] [Full Text] [Related]
4. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.
Salazar A; McAlister VC; Kiberd BA; Bitter-Suermann H; Al-Kerithy MF; MacDonald AS
Transplant Proc; 2001; 33(1-2):1038-9. PubMed ID: 11267181
[No Abstract] [Full Text] [Related]
5. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548
[No Abstract] [Full Text] [Related]
6. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
Stratta RJ; Taylor RJ; Weide LG; Sindhi R; Sudan D; Castaldo P; Cushing KA; Frisbie K; Radio SJ
Transplant Proc; 1996 Apr; 28(2):917-8. PubMed ID: 8623461
[No Abstract] [Full Text] [Related]
7. Analysis of incidence and pattern of acute rejection episodes after simultaneous pancreas and kidney transplantation.
Hiesse C; Paradis V; Benoît G; Kriaa F; Blanchet P; Bellamy J; Larue JR; Charpentier B
Transplant Proc; 1997; 29(1-2):671-2. PubMed ID: 9123473
[No Abstract] [Full Text] [Related]
8. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
9. Can we improve the results of simultaneous pancreas-kidney transplantation?
Fornairon S; Desgrandchamps F; Cattan P; Meria P; Anidjar M; Bedrossian J; Teillac P; Le Duc A; Legendre C
Transplant Proc; 1998 Sep; 30(6):2818-9. PubMed ID: 9745580
[No Abstract] [Full Text] [Related]
10. The fate of renal allografts treated with OKT3 for steroid-resistant rejection.
Veronese FV; Gonçalves LF; Vilarinho LL; Macedo VS; Manfro RC
Transplant Proc; 1999 Nov; 31(7):3016-8. PubMed ID: 10578371
[No Abstract] [Full Text] [Related]
11. Simultaneous pancreas-kidney transplant compared with kidney transplant in Type I diabetic patients with end-stage renal disease.
Pérez R; Navarro MD; del Castillo D; Santamaría R; Padillo J; Regueiro JC; Aljama P
Transplant Proc; 2001; 33(7-8):3494-5. PubMed ID: 11750493
[No Abstract] [Full Text] [Related]
12. The National Transplantation Pregnancy Registry: comparison between pregnancy outcomes in diabetic cyclosporine -treated female kidney recipients and CyA-treated female pancreas-kidney recipients.
Armenti VT; McGrory CH; Cater J; Radomski JS; Jarrell BE; Moritz MJ
Transplant Proc; 1997; 29(1-2):669-70. PubMed ID: 9123472
[No Abstract] [Full Text] [Related]
13. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
[No Abstract] [Full Text] [Related]
14. Combined pancreas-kidney transplantation versus kidney transplantation alone: analysis of benefit and risk.
Stratta RJ; Taylor RJ; Ozaki CF; Bynon JS; Langnas AN; Shaw BW
Transplant Proc; 1993 Feb; 25(1 Pt 2):1298-301. PubMed ID: 8442119
[No Abstract] [Full Text] [Related]
15. Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation.
Desai DM; Scandling JD; Knoppel C; Dafoe DC; Alfrey EJ
Transplant Proc; 1998 Jun; 30(4):1552-4. PubMed ID: 9636630
[No Abstract] [Full Text] [Related]
16. Simultaneous pancreas-kidney transplantation nine years after liver transplantation--a case report.
Marschalek J; Györi GP; Silberhumer GR; Jomrich G; Kristo I; Steininger R; Mühlbacher F; Berlakovich GA
Transplant Proc; 2012 Dec; 44(10):3041-3. PubMed ID: 23195023
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results.
Witzigmann H; Rhein T; Geissler F; Thiery J; Serr F; Tannapfel A; Uhlmann D; Metzner R; Hauss J
Transplant Proc; 2002 Dec; 34(8):3354-6. PubMed ID: 12493472
[No Abstract] [Full Text] [Related]
18. Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.
Woodle ES; Bluestone JA; Zivin RA; Jolliffe LK; Auger J; Xu D; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1369-70. PubMed ID: 9636555
[No Abstract] [Full Text] [Related]
19. The use of OKT3 in steroid-resistant rejections following cadaveric kidney transplantation.
Rosenkranz B; Niebel W; Albrecht K; Wagner K; Philipp T; Eigler FW
Transpl Int; 1992; 5 Suppl 1():S112-3. PubMed ID: 14621750
[TBL] [Abstract][Full Text] [Related]
20. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
Vincenti F; Stock P
Transplant Proc; 2003 May; 35(3 Suppl):183S-186S. PubMed ID: 12742494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
